Masimo Announces 2020 Annual Meeting of Stockholders to be Held as a Virtual Meeting
May 20 2020 - 8:00PM
Business Wire
Masimo Corporation (Nasdaq: MASI) today announced a change to
its 2020 Annual Meeting of Stockholders. Due to conditions
associated with the Coronavirus pandemic (COVID-19), including
restrictions on in-person gatherings, and in order to support the
health and well-being of our stockholders and other meeting
participants, Masimo’s 2020 Annual Meeting of Stockholders will be
held in a virtual meeting format only.
The previously announced date and time of the Annual Meeting,
May 29, 2020 at 2:00 p.m. Pacific Time, will not change. There is
also no change to the items of business to be addressed at the
Annual Meeting, which are described in Masimo’s proxy materials as
previously distributed. As noted above, stockholders may not attend
the Annual Meeting in person. Instead, stockholders should follow
the instructions provided below to attend the virtual Annual
Meeting. Computershare will host the virtual Annual Meeting.
Stockholders are encouraged to vote their shares prior to the
virtual Annual Meeting by any of the methods described in the proxy
materials. The proxy card and voting instructions form included
with the previously distributed proxy materials will not be updated
to reflect the change in the format of the meeting, but they may
continue to be used to vote the shares on the proposals to be
presented at the virtual Annual Meeting. Stockholders who have
previously voted do not need to take any further action.
To access the virtual Annual Meeting, Masimo stockholders should
go to http://www.meetingcenter.io/275841776. Depending on whether
you are a “record holder” or “beneficial owner” of your shares (as
further discussed below), you can log in using one of two options:
join as a “Guest” or join as a “Stockholder.” To join as a “Guest,”
enter your email address and the password, which is
MASI2020. To join as a “Stockholder,” you will be required
to have a control number (and you will also use MASI2020 as
your password). If you join as a Stockholder, you can vote during
the virtual Annual Meeting by following the instructions available
on the meeting website.
Instructions to Attend the Virtual Annual Meeting
Record Holders: Holders of record of Masimo common stock at the
close of business on March 31, 2020 (i.e., shares held in the
holder’s own name in the records of Masimo’s transfer agent,
Computershare) can find their control number on their proxy card or
Notice of Internet Availability, and enter the virtual Annual
Meeting as a “Stockholder.”
Beneficial Owners: Beneficial owners of common stock of Masimo
at the close of business on March 31, 2020 (i.e., shares held in
the “street name” through an intermediary, such as a bank, broker
or other nominee) who wish to vote their shares at the virtual
Annual Meeting as a “Stockholder” must pre-register with
Computershare no later than 5:00 p.m. Eastern Time on May 22, 2020
to obtain a control number. To pre-register, beneficial owners must
first obtain a legal proxy from their bank, broker or other
nominee, and send a copy of their legal proxy to Computershare at
legalproxy@computershare.com, with the words “Legal Proxy” in the
subject line. Beneficial owners will receive a confirmation e-mail
from Computershare confirming their registration and will be
provided a control number to enter the virtual Annual Meeting as a
Stockholder. Beneficial owners who obtain a legal proxy from their
bank broker or other nominee will revoke any prior instructions
provided on how to vote the shares held on their behalf at the
Annual Meeting. If a legal proxy is requested from a bank, broker
or other nominee, they must vote at the virtual Annual Meeting in
order for their vote to be counted. If they do not have a control
number, they may attend as a “Guest,” but will not have the option
to vote their shares or ask questions at the virtual Annual
Meeting.
About Masimo
Masimo (Nasdaq: MASI) is a global medical technology company
that develops and produces a wide array of industry-leading
monitoring technologies, including innovative measurements,
sensors, patient monitors, and automation and connectivity
solutions. Our mission is to improve patient outcomes and reduce
the cost of care. Masimo SET® Measure-through Motion and Low
Perfusion™ pulse oximetry, introduced in 1995, has been shown in
over 100 independent and objective studies to outperform other
pulse oximetry technologies. Masimo SET® has also been shown to
help clinicians reduce severe retinopathy of prematurity in
neonates, improve CCHD screening in newborns, and, when used for
continuous monitoring with Masimo Patient SafetyNet™ in
post-surgical wards, reduce rapid response team activations, ICU
transfers, and costs. Masimo SET® is estimated to be used on more
than 100 million patients in leading hospitals and other healthcare
settings around the world, and is the primary pulse oximetry at 9
of the top 10 hospitals listed in the 2018-19 U.S. News and World
Report Best Hospitals Honor Roll. Masimo continues to refine SET®
and in 2018, announced that SpO2 accuracy on RD SET™ sensors during
conditions of motion has been significantly improved, providing
clinicians with even greater confidence that the SpO2 values they
rely on accurately reflect a patient’s physiological status. In
2005, Masimo introduced rainbow® Pulse CO-Oximetry technology,
allowing noninvasive and continuous monitoring of blood
constituents that previously could only be measured invasively,
including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth
Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve
Index (ORi™). In 2013, Masimo introduced the Root® Patient
Monitoring and Connectivity Platform, built from the ground up to
be as flexible and expandable as possible to facilitate the
addition of other Masimo and third-party monitoring technologies;
key Masimo additions include Next Generation SedLine® Brain
Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography
with NomoLine® sampling lines. Masimo’s family of continuous and
spot-check monitoring Pulse CO-Oximeters® includes devices designed
for use in a variety of clinical and non-clinical scenarios,
including tetherless, wearable technology, such as Radius-7® and
Radius PPG™, portable devices like Rad-67™, fingertip pulse
oximeters like MightySat® Rx, and devices available for use both in
the hospital and at home, such as Rad-97™. Masimo hospital
automation and connectivity solutions are centered around the Iris®
platform, and include Iris Gateway™, Patient SafetyNet, Replica™,
Halo ION™, UniView™, and Doctella™. Additional information about
Masimo and its products may be found at www.masimo.com. Published
clinical studies on Masimo products can be found at
www.masimo.com/evidence/featured-studies/feature/.
Masimo, SET, Signal Extraction Technology, Improving Patient
Outcome and Reducing Cost of Care... by Taking Noninvasive
Monitoring to New Sites and Applications, rainbow, SpHb, SpOC,
SpCO, SpMet, PVI and ORI are trademarks or registered trademarks of
Masimo Corporation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200520005901/en/
Investor Contact: Eli Kammerman (949) 297-7077
ekammerman@masimo.com
Media Contact: Evan Lamb (949) 297-3376
elamb@masimo.com
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Apr 2023 to Apr 2024